This nonrandomized clinical trial examines the efficacy and safety of dasatinib in combination with chimeric antigen receptor T cells as frontline therapy in adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia.
The US Food and Drug Administration (FDA) recently approved lenacapavir, marketed as Yeztugo, as the first twice-yearly preexposure prophylaxis (PrEP) that reduces HIV risk.
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
This cohort study evaluates the association between educational level and disability progression in patients with multiple sclerosis.
This cohort study assesses whether there were changes in the use of cannabis, cigarettes, and electronic nicotine delivery systems among US adults during 5 years…
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
A 76-year-old man presented to the emergency department with a 6-week history of globus sensation and muffled voice and acute onset frank hemoptysis. Laryngoscopy revealed…
This cohort study of adults with advanced cancer compares the use of targeted therapy during first-line therapy for patients with no biomarker testing, comprehensive genomic…
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
This Medical News article is an interview with Raveendhara Bannuru, MD, PhD, vice president of medical affairs at the American Diabetes Association, about clinical highlights…
